IQVIA Holdings Inc. (IQV)

Market Cap	35.86B
Revenue (ttm)	15.90B
Net Income (ttm)	1.28B
Shares Out	170.30M
EPS (ttm)	7.30
PE Ratio	28.76
Forward PE	16.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	778,854
Open	210.00
Previous Close	210.12
Day's Range	208.83 - 211.74
52-Week Range	134.65 - 225.91
Beta	1.38
Analysts	Buy
Price Target	237.89 (+12.97%)
Earnings Date	Oct 28, 2025

About IQV

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2013
• Employees: 88,000
• Stock Exchange: NYSE
• Ticker Symbol: IQV
• Website: https://www.iqvia.com

Financial Performance

In 2024, IQVIA Holdings's revenue was $15.41 billion, an increase of 2.81% compared to the previous year's $14.98 billion. Earnings were $1.37 billion, an increase of 1.10%.

Analyst Summary

According to 18 analysts, the average rating for IQV stock is "Buy." The 12-month stock price target is $237.89, which is an increase of 12.97% from the latest price.

Price Target

$237.89

(12.97% upside)

Analyst Consensus: Buy